BMS strategies
Bristol Myers Squibb aims for 25+ new indications to overcome patent losses and pricing challenges
Anika Sharma
Bristol Myers Squibb is placing a significant bet on its robust pipeline to weather challenges such as the Inflation Reduction ...
